United States

Celator Pharmaceuticals Inc (CPXX)

Track

Stock chart
Ticker: CPXX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Morenstein Scott D
1 purchase — total 9,325 USD
Buy 3 Dec 2015
Value US$4,329,480.12 | Price 424.20 | Shares 60,227
Buy 6 Oct 2015
Value US$4,624,620.69 | Price 315.88 | Shares 36,289
Buy 5 Oct 2015
Value US$24,386.00 | Price 1.78 | Shares 13,700
Buy 1 Oct 2015
Value US$3,280.00 | Price 1.64 | Shares 2,000
Buy 30 Sep 2015
Value US$4,980.00 | Price 1.66 | Shares 3,000
Buy 30 Sep 2015
Value US$3,360.00 | Price 1.68 | Shares 2,000
Buy 30 Sep 2015
Value US$8,100.00 | Price 1.62 | Shares 5,000
Buy 30 Sep 2015
Value US$334.00 | Price 1.67 | Shares 200
Buy 18 Nov 2014
Value US$42,940.00 | Price 2.15 | Shares 20,000
Buy 18 Nov 2014
Value US$13,200.00 | Price 2.20 | Shares 6,000
Buy 18 Nov 2014
Value US$22,000.00 | Price 2.20 | Shares 10,000
Buy 15 May 2014
Value US$6,240.00 | Price 2.50 | Shares 2,500
Buy 17 Dec 2013
Value US$10,490.40 | Price 3.50 | Shares 3,000
Buy 17 Dec 2013
Value US$8,750.00 | Price 3.50 | Shares 2,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-12-07 2015-12-03 B Purchase Morenstein Scott D Non-Executive Director
60,227 -48.2%
424.20
US$4,329,480 		60,227 -48.2% 424.20 US$4,329,480
2015-10-07 2015-10-06 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
36,289 +40.2%
315.88
US$4,624,621 		36,289 +40.2% 315.88 US$4,624,621
2015-10-05 2015-10-05 B Purchase Powell Fred M

VP and Chief Financial Officer

Officer
14,802 +1.1%
470.91
US$3,300,932 		14,802 +1.1% 470.91 US$3,300,932
2015-10-02 2015-10-01 B Purchase Valence Life Sciences GP II LLC
2,000 +1.2%
1.64
US$3,280 		2,000 +1.2% 1.64 US$3,280
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
3,000 +1.8%
1.66
US$4,980 		3,000 +1.8% 1.66 US$4,980
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
2,000 +1.2%
1.68
US$3,360 		2,000 +1.2% 1.68 US$3,360
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
5,000 +3.1%
1.62
US$8,100 		5,000 +3.1% 1.62 US$8,100
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
200 +0.1%
1.67
US$334 		200 +0.1% 1.67 US$334
2014-11-20 2014-11-18 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
20,000 +inf%
2.15
US$42,940 		20,000 +inf% 2.15 US$42,940
2014-11-18 2014-11-18 B Purchase Powell Fred M

Chief Financial Officer

Officer
6,000 +120.0%
2.20
US$13,200 		6,000 +120.0% 2.20 US$13,200
2014-11-18 2014-11-18 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
10,000 +333.3%
2.20
US$22,000 		10,000 +333.3% 2.20 US$22,000
2014-05-16 2014-05-15 B Purchase Powell Fred M

Chief Financial Officer

Officer
2,500 +100.0%
2.50
US$6,240 		2,500 +100.0% 2.50 US$6,240
2013-12-17 2013-12-17 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
3,000 +inf%
3.50
US$10,490 		3,000 +inf% 3.50 US$10,490
2013-12-17 2013-12-17 B Purchase Powell Fred M

VP and CFO

Officer
2,500 +inf%
3.50
US$8,750 		2,500 +inf% 3.50 US$8,750
Explore more

More insider trading research around Celator Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America